Upon completion of this activity, participants should be able to: 1. Select guideline congruent treatment for HSCT recipients according to their grade of acute graft vs host disease (aGvHD). 2. Identify the potential role of new data and ongoing clinical trials of emerging therapies in addressing unmet needs in post-HSCT aGvHD management. 3. Integrate the unique roles and responsibilities of interprofessional care team members when managing HSCT-recipients with aGvHD.
- Provider:RMEI Medical Education, LLC
- Activity Link: https://rmei.com
- Start Date: 2024-06-20 05:00:00
- End Date: 2024-06-20 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: CSL Behring, LLC - Amount: 205455.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology, Transplant Hepatology
Subscribe
Login
0 Comments
Oldest